SCHEMBL8773709

SCHEMBL8773709

CC(=O)Oc1cc(I)c(O)c(I)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
LMNA P02545 6/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
TTR P02766 4/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
THRB P10828 3/20 0.43
PPARG P37231 3/20 0.43
THRA P10827 2/20 0.43
RXRA P19793 2/20 0.43
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
BACE1 P56817 1/20 0.43
ADORA3 P0DMS8 2/20 0.41
PDE4D Q08499 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063642 0.83 MEN1 (0.47) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL5928053 0.83 THRB (0.41) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL2010436 0.80 LMNA (0.59) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL26794108 0.79 ELANE (0.45) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL7094541 0.79 CYP3A4 (0.55) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL7586397 0.79 LMNA (0.50) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL3688841 0.77 LMNA (0.50) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL23022578 0.77 CYP3A4 (0.53) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL3688838 0.77 KMT2A (0.47) CYP3A4LMNAMEN1KMT2ATTR
SCHEMBL12764452 0.77 THRB (0.64) CYP3A4LMNAMEN1KMT2ATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0802798-A1 METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS CHIRON CORPORATION (US) 1997-10-29 EP disclosed
WO-1995022992-A1 METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS CHIRON CORPORATION (US) 1995-08-31 WO disclosed